These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19262359)

  • 1. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India.
    Sharma S; Joshi S; Chadda RK
    Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up of patients that use lithium].
    Solberg DK; Refsum H
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1410-2. PubMed ID: 18552904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation in plasma levels of lithium in the Indian population: is there a need to modify the dose?
    Medhi B; Prakash O; Jose VM; Pradhan B; Chakrabarty S; Pandhi P
    Singapore Med J; 2008 Sep; 49(9):724-7. PubMed ID: 18830549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study.
    Wilting I; Heerdink ER; Mersch PP; den Boer JA; Egberts AC; Nolen WA
    Bipolar Disord; 2009 Jun; 11(4):434-40. PubMed ID: 19500096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels.
    Palma JA; Fernandez-Torron R; Gallego Perez-Larraya J
    Clin Neuropharmacol; 2010; 33(2):102-3. PubMed ID: 20375657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders.
    Mann K; Hiemke C; Lotz J; Schmidt LG; Lackner KJ; Bates DW
    J Clin Psychopharmacol; 2006 Dec; 26(6):671-3. PubMed ID: 17110832
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring: appropriateness and clinical utility in neuropsychiatry practice.
    Sharma S; Joshi S; Mukherji S; Bala K; Tripathi CB
    Am J Ther; 2009; 16(1):11-6. PubMed ID: 19092643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder.
    Farooq S; Nazar Z; Akhtar J; Irfan M; Subhan F; Ahmed Z; Khan EH; Naeem F
    Int Clin Psychopharmacol; 2010 Nov; 25(6):323-7. PubMed ID: 20827213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium in bipolar and other affective disorders: prescribing practice in the UK.
    Paton C; Barnes TR; Shingleton-Smith A; McAllister-Williams RH; Kirkbride J; Jones PB; McIntyre S;
    J Psychopharmacol; 2010 Dec; 24(12):1739-46. PubMed ID: 20488832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
    Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
    J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J; Kaston B
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency.
    Gerrett D; Lamont T; Paton C; Barnes TR; Shah A
    BMJ; 2010 Nov; 341():c6258. PubMed ID: 21097572
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.